Cargando…

Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction

The objective of the study was to identify the profile of circulating C19MC microRNAs (miR-516-5p, miR-517∗, miR-518b, miR-520a∗, miR-520h, miR-525, and miR-526a) in patients with established preeclampsia (n = 63), fetal growth restriction (n = 27), and gestational hypertension (n = 23). We examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromadnikova, Ilona, Kotlabova, Katerina, Ondrackova, Marketa, Kestlerova, Andrea, Novotna, Veronika, Hympanova, Lucie, Doucha, Jindrich, Krofta, Ladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848305/ https://www.ncbi.nlm.nih.gov/pubmed/24347821 http://dx.doi.org/10.1155/2013/186041

Ejemplares similares

Circulating heat shock protein mRNA profile in gestational hypertension, pre-eclampsia & foetal growth restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension
por: Hromadnikova, Ilona, et al.
Publicado: (2014)

Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2015)

The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Association Analysis in Young and Middle-Aged Mothers—Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

First-Trimester Screening for Miscarriage or Stillbirth—Prediction Model Based on MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus—One of Several Possible Reasons for an Increased Cardiovascular Risk
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Association Analysis in Children Born from Normal and Complicated Pregnancies—Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies
por: Kotlabova, Katerina, et al.
Publicado: (2013)

Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

The Effects of Prenatal Pravastatin Treatment in the Rabbit Fetal Growth Restriction Model
por: Zapletalova, Katerina, et al.
Publicado: (2023)

Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies
por: Hromadnikova, Ilona, et al.
Publicado: (2002)

Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension
por: Zheng, Weizeng, et al.
Publicado: (2022)

Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
por: Gong, Sungsam, et al.
Publicado: (2018)

Proteomic analysis of the umbilical cord in fetal growth restriction and preeclampsia
por: Conrad, Matthew S., et al.
Publicado: (2022)

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction
por: Pedroso, Marianna Amaral, et al.
Publicado: (2018)

Differential Gene Expression at the Maternal-Fetal Interface in Preeclampsia Is Influenced by Gestational Age
por: Lian, Ingrid A., et al.
Publicado: (2013)

Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction
por: Youssef, Lina, et al.
Publicado: (2021)

Effect of Endogenic and Exogenic Oxidative Stress Triggers on Adverse Pregnancy Outcomes: Preeclampsia, Fetal Growth Restriction, Gestational Diabetes Mellitus and Preterm Birth
por: Joo, Eun Hui, et al.
Publicado: (2021)

Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction
por: Bujold, Emmanuel, et al.
Publicado: (2021)

Upregulation of ENDOU in cytotrophoblasts from placenta complicated with preeclampsia and fetal growth restriction
por: Nomoto, Masataka, et al.
Publicado: (2021)

Appearance of levator ani muscle subdivision defects on level III vaginal support structures in women with and without pelvic organ prolapse: an MRI study
por: Horcicka, L., et al.
Publicado: (2023)

Are Twin Pregnancies Complicated by Weight Discordance or Fetal Growth Restriction at Higher Risk of Preeclampsia?
por: Giorgione, Veronica, et al.
Publicado: (2020)

Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction
por: de Alwis, Natasha, et al.
Publicado: (2022)

Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
por: Tousty, Piotr, et al.
Publicado: (2023)

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
por: Hromadnikova, Ilona, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_42v6m9uhru5rg47jemaq9alpdg